High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis
J Wang, Q Zhang, R Zhou, B Chen, J Ouyang - PLoS One, 2012 - journals.plos.org
Background and Objectives Several trials have generated conflicting results about the
results of high-dose chemotherapy followed by autologous stem cell transplantation (HDCT) …
results of high-dose chemotherapy followed by autologous stem cell transplantation (HDCT) …
High-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk primary breast cancer
P Pedrazzoli, M Martino, S Delfanti… - Journal of the …, 2015 - academic.oup.com
Background: The efficacy of high-dose chemotherapy (HDC) and autologous hematopoietic
stem cell transplantation for breast cancer (BC) has been an area of intense controversy …
stem cell transplantation for breast cancer (BC) has been an area of intense controversy …
247: High-Dose Chemotherapy with Autologous Stem-Cell Support Versus Standard-Dose Chemotherapy for High-Risk Breast Cancer: Meta-Analysis of Individual …
Background: The role of adjuvant high-dose chemotherapy (HDC) with autologous
hematopoietic stem-cell transplantation for primary breast cancer at high risk of recurrence …
hematopoietic stem-cell transplantation for primary breast cancer at high risk of recurrence …
High dose chemotherapy for poor prognosis breast cancer: systematic review and meta-analysis
CM Farquhar, J Marjoribanks, A Lethaby… - Cancer treatment …, 2007 - Elsevier
BACKGROUND: High dose chemotherapy with autologous transplantation of bone marrow
or peripheral stem cells (autograft) has been considered promising for treating poor …
or peripheral stem cells (autograft) has been considered promising for treating poor …
High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomized …
Abstract Abstract# 6113 Background: The role of high-dose chemotherapy (HDC) with
autologous hematopoietic stem-cell transplantation for metastatic breast cancer has not …
autologous hematopoietic stem-cell transplantation for metastatic breast cancer has not …
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials
Purpose Adjuvant high-dose chemotherapy (HDC) with autologous hematopoietic stem-cell
transplantation (AHST) for high-risk primary breast cancer has not been shown to prolong …
transplantation (AHST) for high-risk primary breast cancer has not been shown to prolong …
Status of high-dose chemotherapy for breast cancer: a review
Y Nieto, RE Champlin, JR Wingard… - Biology of Blood and …, 2000 - Elsevier
The purpose of this review is to analyze the current status of high-dose chemotherapy
(HDCT) with autologous stem cell transplantation for patients with breast cancer. Current …
(HDCT) with autologous stem cell transplantation for patients with breast cancer. Current …
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer
A Schneeweiss, M Hensel, R Goerner, T Khbeis… - Stem …, 2001 - academic.oup.com
In patients with metastatic breast cancer (MBC), early dose intensification with multiple
cycles of peripheral blood stem cell-supported high-dose chemotherapy (HDCT) seems …
cycles of peripheral blood stem cell-supported high-dose chemotherapy (HDCT) seems …
Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients
M Martino, A Bottini, G Rosti, D Generali… - Expert Opinion on …, 2012 - Taylor & Francis
Introduction: High-dose chemotherapy (HDC) with autologous hematopoietic progenitor cell
transplantation (AHPCT) for high-risk (HR) or metastatic breast cancer (MBC) is no longer an …
transplantation (AHPCT) for high-risk (HR) or metastatic breast cancer (MBC) is no longer an …
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast …
C Farquhar, J Marjoribanks… - Cochrane Database …, 2016 - cochranelibrary.com
Background Overall survival rates are disappointing for women with early poor prognosis
breast cancer. Autologous transplantation of bone marrow or peripheral stem cells (in which …
breast cancer. Autologous transplantation of bone marrow or peripheral stem cells (in which …